\
&
Contact us
\
&
Contact us
Published on | 1 year ago
ProgrammesThe Joint Research Centre opens its scientific laboratories and facilities to people working in academia and research organisations, industry, SMEs, and more in general to the public and private sector.
The JRC offers access to its non-nuclear facilities to researchers and scientists from EU Member States and countries associated to the EU Research Programme Horizon Europe. For nuclear facilities, the JRC opens to EU Member States and to countries associated to the Euratom Research Programme.
There are 5 open calls at the moment:
For information on the dedicated JRC website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Research Infrastructures Health Culture and society Civil Security
More information is available about opportunities for transnational (TNA) and virtual access (VA) to European research infrastructures for researchers from the academic and private sector in this RICH Europe leaflet. Access the database on TNA and VA open calls here. The database can be filtered on scientific domain, the status of th... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
